Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Spiegelman Daniel K
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   148,092    

Indirect Shares

   6,673      
Direct Value   $4,955,193    

Indirect Value

   $0      
Total Shares   154,765      
Total Value   $4,955,193      


CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $728,782 CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $728,782
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            CV Therapeutics Inc CVTX SVP, CFO 2009-04-09 67,489 2009-04-09 6,673    Premium*  
            Cascadian Therapeutics, Inc CASC Director 2018-03-09 0 2009-12-04 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Financial O... 2019-04-30 47,686 2012-05-29 0    Premium*  
            Relypsa Inc RLYP Director 2016-09-01 0 2015-06-04 0    Premium*  
            Myriad Genetics Inc MYGN Director 2024-06-04 32,917 2020-05-27 0    Premium*  
* Premium Members only  

Records found :    182         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CASC Cascadian Therapeutics, I... Director   –       •      –    2014-06-07 4 D $3.06 $6,255 D/D (2,044) 36,827 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-15 4 D $122.78 $211,427 D/D (1,722) 77,644 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-29 4 D $125.57 $540,579 D/D (4,305) 37,202 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-06-04 4 D $120.46 $216,948 D/D (1,801) 29,878 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2015-06-13 4 D $3.88 $15,563 D/D (4,011) 52,675 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-02-29 4 D $81.87 $3,828,732 D/D (46,766) 54,311 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-03-03 4 D $89.57 $214,520 D/D (2,395) 47,293 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-13 4 D $82.71 $142,427 D/D (1,722) 62,413 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-27 4 D $89.09 $383,532 D/D (4,305) 54,339 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-06-03 4 D $90.00 $162,090 D/D (1,801) 48,593 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2016-06-06 5 D $7.38 $5,026 D/D (681) 10,821 0 -
RLYP Relypsa Inc Director   –       •      –    2016-09-01 4 D $32.00 $72,000 D/D (2,250) 0 0 -
RLYP Relypsa Inc Director   –       •      –    2016-09-01 4 D $32.00 $39,584 D/D (1,237) 2,250 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-03-03 4 D $93.95 $214,488 D/D (2,283) 23,064 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-03-15 4 D $92.50 $397,843 D/D (4,301) 16,460 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-05-15 4 D $91.50 $157,563 D/D (1,722) 25,104 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-06-02 4 D $90.72 $163,387 D/D (1,801) 23,303 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2017-06-12 4 D $3.34 $1,794 D/D (537) 12,432 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2017-06-24 4 D $3.78 $8,562 D/D (2,265) 19,225 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2017-09-24 4 D $3.94 $2,340 D/D (594) 21,006 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-03-02 4 D $79.86 $128,495 D/D (1,609) 68,520 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2018-03-09 4 D $0.00 $0 D/D (21,006) 0 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-03-15 4 D $83.57 $318,820 D/D (3,815) 64,705 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-03-22 4 D $81.36 $291,513 D/D (3,583) 73,602 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-03-22 4/A D $81.36 $292,733 D/D (3,598) 73,587 0 -
  182  Records found
  1   2   3   4   5  6   7   8      
  Page 5 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us